Myopic Choroidal Neovascularization - Anti-vascular Endothelial Growth Factor Therapeutics Market Statistics
Related Statistics
Myopic Choroidal Neovascularization - Anti-vascular endothelial growth factor therapeutics market highlights
- The global myopic choroidal neovascularization segment generated a revenue of USD 421.6 million in 2024 and is expected to reach USD 362.5 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of -2.9% by 2030.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
Market summary
| Market revenue in 2024 | USD 421.6 million |
| Market revenue in 2030 | USD 362.5 million |
| Growth rate | -2.9% (CAGR from 2025 to 2030) |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-Vascular Endothelial Growth Factor Therapeutics Market Scope
Anti-vascular endothelial growth factor therapeutics market segmentation & scope
Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook
- HTML
- PPT
- -
Everything on Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook in one document: edited and divided into chapters, including detailed references.
Related industry reports
Related Regional Reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
